Skip to main content
SpringerLink
Log in

Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers

  • Pharmacogenetics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

The antihypertensive effect of thiazide diuretics has recently been associated with genetic variation in the angiotensin I-converting enzyme (ACE), alpha-adducin (ADD1) and the G protein subunit β3 (GNB3). Analysis of short-term diuretic effects may provide insight into the mechanisms behind these findings.

Methods

A total of 103 male volunteers took 25 and 100 mg hydrochlorothiazide (HCT) after a placebo day, each. We measured volume, sodium, chloride, potassium, calcium excretion, blood pressure and heart rate.

Results

Excretion and cardiovascular parameters were highly constant between the 2 placebo days. The resting heart rate was 2–3 beats/minute (bpm) higher per ACE insertion allele on all 4 study days. The HCT-induced excretion of sodium, chloride and volume was independent of the genotypes. The additional potassium excretion induced by 100 mg HCT was 44±21, 33±27 and 16±26 mmol (mean±SD, p<0.001) in ACE II, ID and DD carriers and the same trend was observed after 25 mg HCT. As a second finding, the 100 mg HCT-induced calcium retention was 0.2±1.2, 0.7±0.8 and 1.7±2.1 mmol in ADD1 Gly/Gly, Gly/Trp and Trp/Trp carriers (p=0.002) and the same trend existed after 25 mg HCT.

Conclusion

The effects of genetic polymorphisms were stronger with the higher diuretic dose. ACE insertion allele carriers appeared to be more prone to hypokalaemia than deletion allele carriers. ADD1 Trp460 carriers may especially benefit from the calcium-sparing effect of thiazides. Both associations should be further studied in long-term treatment with thiazide diuretics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997

    Article  Google Scholar 

  2. Vormfelde SV, Burckhardt G, Zirk A, Wojnowski L, Brockmoller J (2003) Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research. Pharmacogenomics 4:701–734

    Article  PubMed  CAS  Google Scholar 

  3. Schelleman H, Stricker BH, De Boer A, Kroon AA, Verschuren MW, Van Duijn CM, Psaty BM, Klungel OH (2004) Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 64:1801–1816

    Article  PubMed  CAS  Google Scholar 

  4. Turner ST, Schwartz GL (2005) Gene markers and antihypertensive therapy. Curr Hypertens Rep 7:21–30

    Article  PubMed  CAS  Google Scholar 

  5. Bennett WM, McDonald WJ, Kuehnel E, Hartnett MN, Porter GA (1977) Do diuretics have antihypertensive properties independent of natriuresis? Clin Pharmacol Ther 22:499–504

    PubMed  CAS  Google Scholar 

  6. Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L (2003) Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest 33:41–50

    Article  PubMed  CAS  Google Scholar 

  7. Rejnmark L, Mosekilde L, Andreasen F (1998) Diuretics and osteoporosis (in Danish). Nord Med 113:53–59

    PubMed  CAS  Google Scholar 

  8. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE (2000) Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 133:516–526

    PubMed  CAS  Google Scholar 

  9. Beermann B, Groschinsky–Grind M (1980) Clinical pharmacokinetics of diuretics. Clin Pharmacokinet 5:221–245

    Article  PubMed  CAS  Google Scholar 

  10. Beermann B, Groschinsky–Grind M (1977) Pharmacokinetics of hydrochlorothiazide in man. Eur J Clin Pharmacol 12:297–303

    Article  PubMed  CAS  Google Scholar 

  11. Cambien F, Alhenc–Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, Allegrini J, Bloch C (1988) Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet 43:774–780

    PubMed  CAS  Google Scholar 

  12. Rigat B, Hubert C, Alhenc–Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346

    PubMed  CAS  Google Scholar 

  13. Arnett DK, Davis BR, Ford CE, Boerwinkle E, Leiendecker–Foster C, Miller MB, Black H, Eckfeldt JH (2005) Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Circulation 111:3374–3383

    Article  PubMed  CAS  Google Scholar 

  14. Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D (2003) ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 41:398–403

    Article  PubMed  CAS  Google Scholar 

  15. Glorioso N, Filigheddu F, Cusi D, Troffa C, Conti M, Natalizio M, Argiolas G, Barlassina C, Bianchi G (2002) alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives. Hypertension 39:357–362

    Article  PubMed  CAS  Google Scholar 

  16. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G (1997) Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 349:1353–1357

    Article  PubMed  CAS  Google Scholar 

  17. Turner ST, Chapman AB, Schwartz GL, Boerwinkle E (2003) Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am J Hypertens 16:834–839

    Article  PubMed  CAS  Google Scholar 

  18. Siffert W (2005) G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 56:17–28

    Article  PubMed  CAS  Google Scholar 

  19. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E (2001) C825T polymorphism of the G protein beta(3)–subunit and antihypertensive response to a thiazide diuretic. Hypertension 37:739–743

    PubMed  CAS  Google Scholar 

  20. Feng Y, Niu T, Xu X, Chen C, Li Q, Qian R, Wang G, Xu X (2002) Insertion/deletion polymorphism of the ACE gene is associated with type 2 diabetes. Diabetes 51:1986–1988

    Article  PubMed  CAS  Google Scholar 

  21. Haszon I, Friedman AL, Papp F, Bereczki C, Baji S, Bodrogi T, Karoly E, Endreffy E, Turi S (2002) ACE gene polymorphism and renal scarring in primary vesicoureteric reflux. Pediatr Nephrol 17:1027–1031

    Article  PubMed  Google Scholar 

  22. Isaac G, Holland OB (1992) Drug-induced hypokalaemia. A cause for concern. Drugs Aging 2:35–41

    PubMed  CAS  Google Scholar 

  23. Gennari FJ (1998) Hypokalemia. N Engl J Med 339:451–458

    Article  PubMed  CAS  Google Scholar 

  24. Velazquez H (1987) Thiazide diuretics. Ren Physiol 10:184–197

    PubMed  CAS  Google Scholar 

  25. Cruz DN (2001) The renal tubular Na–Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density? Nephrol Dial Transplant 16:691–694

    Article  PubMed  CAS  Google Scholar 

  26. Legroux-Gerot I, Catanzariti L, Marchandise X, Duquesnoy B, Cortet B (2004) Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics. Joint Bone Spine 71:51–55

    Article  PubMed  Google Scholar 

  27. Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH (2003) Thiazide diuretics and the risk for hip fracture. Ann Intern Med 139:476–482

    PubMed  Google Scholar 

  28. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of beta-blockers and risk of fractures. JAMA 292:1326–1332

    Article  PubMed  CAS  Google Scholar 

  29. Schunkert H, Hense HW, Doring A, Riegger GA, Siffert W (1998) Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 32:510–513

    PubMed  CAS  Google Scholar 

  30. Lee SY, Maniak PJ, Rhodes R, Ingbar DH, O’Grady SM (2003) Basolateral Cl-transport is stimulated by terbutaline in adult rat alveolar epithelial cells. J Membr Biol 191:133–139

    Article  PubMed  CAS  Google Scholar 

  31. Velazquez H, Silva T (2003) Cloning and localization of KCC4 in rabbit kidney: expression in distal convoluted tubule. Am J Physiol Renal Physiol 285:F49–F58

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology University Medical Center, Georg-August-University, Robert-Koch-Str. 40, 37075, Göttingen, Germany

    Stefan Viktor Vormfelde, Daniel Sehrt, Daniela Bolte, Susanne Pahl, Mladen Tzvetkov & Jürgen Brockmöller

Authors
  1. Stefan Viktor Vormfelde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Sehrt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela Bolte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susanne Pahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mladen Tzvetkov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jürgen Brockmöller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Viktor Vormfelde.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vormfelde, S.V., Sehrt, D., Bolte, D. et al. Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers. Eur J Clin Pharmacol 62, 195–201 (2006). https://doi.org/10.1007/s00228-005-0081-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0081-z

Keywords

Search

Navigation